Opioid analgesics – a 2018 update

  • Gustav Schellack
  • Natalie Schellack Sefako Makgatho Health Sciences University
  • Hannelie (JC) Meyer Sefako Makgatho Health Sciences University
Keywords: Pain, opioid, morphine, codeine, oxycodone, hydromorphone, buprenorphine, pain ladder, tapentadol

Abstract

The opioid analgesic drugs constitute one of the most important groups of pharmacotherapeutic agents in the clinical practice setting. They are vital to pain management, especially moderate to severe cancer and visceral pain, in a myriad of healthcare settings. The key to optimal pain management is the ability to effectively manage patients to ensure optimal pain relief, whilst also minimising or managing the side-effects of their pain medication. This necessitates effective collaboration between all the healthcare professionals managing the patient. This article provides an updated overview of the opioid analgesics, and their usefulness in clinical practice.

Author Biographies

Gustav Schellack
BCur, Adv Univ Dipl Nurs Sc (HSM), Hons BSc (Pharmacology) Clinical research specialist in the pharmaceutical industry
Natalie Schellack, Sefako Makgatho Health Sciences University
BCur, BPharm, PhD (Pharmacy) Associate Professor Department of Pharmacy Faculty of Health Sciences Sefako Makgatho Health Sciences University
Hannelie (JC) Meyer, Sefako Makgatho Health Sciences University
BPharm, MSc (Med) Pharmacy, PhD (Pharmacy) Associate Professor School of Pharmacy Sefako Makgatho Health Sciences University
Section
Reviews